The Cutting Edge of Cutting Calories

Illustration: A. Canamucio The sad truth is that we're a bunch of fatsos, and getting fatter. Sixty-one percent of adults are now overweight, an all-time high, and more than a quarter are actually obese, or grossly overweight, according to the 1999 National Health and Nutrition Examination Survey just released by the Centers for Disease Control and Prevention. But while we get fatter and suffer from diabetes and high cholesterol in record numbers, federal regulators are drastically limit

Written byHenry Miller
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Illustration: A. Canamucio
The sad truth is that we're a bunch of fatsos, and getting fatter. Sixty-one percent of adults are now overweight, an all-time high, and more than a quarter are actually obese, or grossly overweight, according to the 1999 National Health and Nutrition Examination Survey just released by the Centers for Disease Control and Prevention.

But while we get fatter and suffer from diabetes and high cholesterol in record numbers, federal regulators are drastically limiting the availability of an important tool for controlling calories. Five years ago the Food and Drug Administration approved a formidable weapon in the war against dietary fat: a cooking oil called olestra, which adds no fat or calories to food. Simply a molecule of table sugar linked to soybean or cottonseed oil, it is too large for the body to absorb or digest. In 1996, after analyzing copious data, consulting outside experts, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies